| Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas Q Deng, G Han, N Puebla-Osorio, MCJ Ma, P Strati, B Chasen, E Dai, ... Nature medicine 26 (12), 1878-1887, 2020 | 387 | 2020 |
| Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification P Strati, TD Shanafelt Blood, The Journal of the American Society of Hematology 126 (4), 454-462, 2015 | 288 | 2015 |
| Eradication of bone marrow minimal residual disease may prompt early treatment discontinuation in CLL P Strati, MJ Keating, SM O'Brien, J Burger, A Ferrajoli, N Jain, ... Blood, The Journal of the American Society of Hematology 123 (24), 3727-3732, 2014 | 190 | 2014 |
| Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma CC Pinnix, JR Gunther, BS Dabaja, P Strati, P Fang, MC Hawkins, ... Blood advances 4 (13), 2871-2883, 2020 | 183 | 2020 |
| Phase I/II trial of the combination of midostaurin (PKC412) and 5‐azacytidine for patients with acute myeloid leukemia and myelodysplastic syndrome P Strati, H Kantarjian, F Ravandi, A Nazha, G Borthakur, N Daver, T Kadia, ... American journal of hematology 90 (4), 276-281, 2015 | 169 | 2015 |
| Venetoclax for AML: changing the treatment paradigm DA Pollyea, M Amaya, P Strati, MY Konopleva Blood advances 3 (24), 4326-4335, 2019 | 166 | 2019 |
| Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma P Strati, S Ahmed, P Kebriaei, LJ Nastoupil, CM Claussen, G Watson, ... Blood Advances 4 (13), 3123-3127, 2020 | 151 | 2020 |
| Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma P Strati, S Ahmed, F Furqan, LE Fayad, HJ Lee, SP Iyer, R Nair, ... Blood, The Journal of the American Society of Hematology 137 (23), 3272-3276, 2021 | 135 | 2021 |
| FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemia N Daver, P Strati, E Jabbour, T Kadia, R Luthra, S Wang, K Patel, ... American journal of hematology 88 (1), 56-59, 2013 | 122 | 2013 |
| Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphoma P Strati, A Varma, S Adkins, LJ Nastoupil, JR Westin, FB Hagemeister, ... Haematologica 106 (10), 2667, 2021 | 112 | 2021 |
| Magnesium sensing via LFA-1 regulates CD8+ T cell effector function J Lötscher, AAM i Líndez, N Kirchhammer, E Cribioli, GMPG Attianese, ... Cell 185 (4), 585-602. e29, 2022 | 111 | 2022 |
| Outcome of patients with low‐risk and intermediate‐1‐risk myelodysplastic syndrome after hypomethylating agent failure: a report on behalf of the MDS Clinical Research Consortium EJ Jabbour, G Garcia‐Manero, P Strati, A Mishra, NH Al Ali, E Padron, ... Cancer 121 (6), 876-882, 2015 | 108 | 2015 |
| Should IGHV status and FISH testing be performed in all CLL patients at diagnosis? A systematic review and meta-analysis SA Parikh, P Strati, M Tsang, CP West, TD Shanafelt Blood, The Journal of the American Society of Hematology 127 (14), 1752-1760, 2016 | 101 | 2016 |
| Lenalidomide induces long-lasting responses in elderly patients with chronic lymphocytic leukemia P Strati, MJ Keating, WG Wierda, XC Badoux, S Calin, JM Reuben, ... Blood, The Journal of the American Society of Hematology 122 (5), 734-737, 2013 | 101 | 2013 |
| Relationship between co‐morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study P Strati, SA Parikh, KG Chaffee, NE Kay, TG Call, SJ Achenbach, ... British journal of haematology 178 (3), 394-402, 2017 | 99 | 2017 |
| Renal complications in chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis: the Mayo Clinic experience P Strati, SH Nasr, N Leung, CA Hanson, KG Chaffee, SM Schwager, ... Haematologica 100 (9), 1180, 2015 | 92 | 2015 |
| Prevalence and characteristics of central nervous system involvement by chronic lymphocytic leukemia P Strati, JH Uhm, TJ Kaufmann, C Nabhan, SA Parikh, CA Hanson, ... Haematologica 101 (4), 458, 2016 | 89 | 2016 |
| Outcomes of first-line treatment for chronic lymphocytic leukemia with 17p deletion P Strati, MJ Keating, SM O’Brien, A Ferrajoli, J Burger, S Faderl, ... Haematologica 99 (8), 1350, 2014 | 86 | 2014 |
| Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new‐onset cytopenia P Strati, W Wierda, J Burger, A Ferrajoli, C Tam, S Lerner, MJ Keating, ... Cancer 119 (21), 3805-3811, 2013 | 86 | 2013 |
| CAR T-cell therapy for B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia: clinical trials and real-world experiences C Vitale, P Strati Frontiers in oncology 10, 849, 2020 | 85 | 2020 |
